@article{3002952,
    title = "International consensus on (ICON) pediatric asthma",
    author = "Papadopoulos, N.G. and Arakawa, H. and Carlsen, K.-H. and Custovic, A. and Gern, J. and Lemanske, R. and Le Souef, P. and Mäkelä, M. and Roberts, G. and Wong, G. and Zar, H. and Akdis, C.A. and Bacharier, L.B. and Baraldi, E. and Van Bever, H.P. and De Blic, J. and Boner, A. and Burks, W. and Casale, T.B. and Castro-Rodriguez, J.A. and Chen, Y.Z. and El-Gamal, Y.M. and Everard, M.L. and Frischer, T. and Geller, M. and Gereda, J. and Goh, D.Y. and Guilbert, T.W. and Hedlin, G. and Heymann, P.W. and Hong, S.J. and Hossny, E.M. and Huang, J.L. and Jackson, D.J. and De Jongste, J.C. and Kalayci, O. and Aït-Khaled, N. and Kling, S. and Kuna, P. and Lau, S. and Ledford, D.K. and Lee, S.I. and Liu, A.H. and Lockey, R.F. and Lãdrup-Carlsen, K. and Lötvall, J. and Morikawa, A. and Nieto, A. and Paramesh, H. and Pawankar, R. and Pohunek, P. and Pongracic, J. and Price, D. and Robertson, C. and Rosario, N. and Rossenwasser, L.J. and Sly, P.D. and Stein, R. and Stick, S. and Szefler, S. and Taussig, L.M. and Valovirta, E. and Vichyanond, P. and Wallace, D. and Weinberg, E. and Wennergren, G. and Wildhaber, J. and Zeiger, R.S.",
    journal = "Allergy: European Journal of Allergy and Clinical Immunology",
    year = "2012",
    volume = "67",
    number = "8",
    pages = "976-997",
    doi = "10.1111/j.1398-9995.2012.02865.x",
    keywords = "allergen;  beclometasone dipropionate;  budesonide;  chromone derivative;  ciclesonide;  flunisolide;  immunoglobulin E;  leukotriene receptor blocking agent;  mometasone furoate;  omalizumab;  theophylline;  triamcinolone acetonide;  vitamin D;  zafirlukast, article;  asthma;  atopy;  bronchodilatation;  consensus;  disease control;  disease exacerbation;  disease severity;  drug delivery system;  drug efficacy;  drug safety;  environmental exposure;  forced expiratory volume;  health care personnel;  health education;  human;  immunotherapy;  lung function;  pathogenesis;  pathophysiology;  patient care;  patient compliance;  peak expiratory flow;  powder inhaler;  practice guideline;  priority journal;  quality of life;  respiratory tract inflammation;  risk benefit analysis;  risk factor;  treatment outcome;  vitamin supplementation, Adolescent;  Asthma;  Child;  Child, Preschool;  Humans;  Infant;  Infant, Newborn",
    abstract = "Asthma is the most common chronic lower respiratory disease in childhood throughout the world. Several guidelines and/or consensus documents are available to support medical decisions on pediatric asthma. Although there is no doubt that the use of common systematic approaches for management can considerably improve outcomes, dissemination and implementation of these are still major challenges. Consequently, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), recently formed by the EAACI, AAAAI, ACAAI, and WAO, has decided to propose an International Consensus on (ICON) Pediatric Asthma. The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. The principles of pediatric asthma management are generally accepted. Overall, the treatment goal is disease control. To achieve this, patients and their parents should be educated to optimally manage the disease, in collaboration with healthcare professionals. Identification and avoidance of triggers is also of significant importance. Assessment and monitoring should be performed regularly to re-evaluate and fine-tune treatment. Pharmacotherapy is the cornerstone of treatment. The optimal use of medication can, in most cases, help patients control symptoms and reduce the risk for future morbidity. The management of exacerbations is a major consideration, independent of chronic treatment. There is a trend toward considering phenotype-specific treatment choices; however, this goal has not yet been achieved. © 2012 John Wiley & Sons A/S."
}